East Tennessee State University hosted a discussion forum with members of the National Security Commission on Emerging Biotechnology Wednesday to examine the region’s role in the U.S. biotechnology ...
Dr. Hing C. Wong, the Founder and CEO of HCW Biologics, is participating as a panelist at the prestigious 2025 GenScript Biotech Global Forum, highlighting the company's expertise and commitment to ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme Corp. (NASDAQ: GENZ) reported today that discussions between its financial advisors and financial advisors for Sanofi-Aventis are continuing and have ...
Panel discussions brought to life important insights into how AI could change the face of biopharma drug discovery in 2026 and beyond PISCATAWAY, N.J., Jan. 29, 2026 /PRNewswire/ -- GenScript Biotech ...
REHOVOT, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek ...
LONDON, Nov. 21, 2024 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech ...
SAN FRANCISCO--(BUSINESS WIRE)--Blade Therapeutics, Inc., a clinical-stage biopharmaceutical company developing cutting-edge treatments for debilitating fibrotic and neurodegenerative diseases, today ...
NANJING, China, Dec. 24, 2023 /PRNewswire/ -- The innovative development of biopharmaceuticals has ushered in a new era for disease treatment, bringing unprecedented hope to countless patients.
International Biotechnology and Pharmaceutical Industry Forum will be held on 11-13 December 2017 in India with the theme "Challenges in Biotechnology and pharma Industry". This forum is brought to ...
BERLIN, July 11, 2011 /PRNewswire/ -- John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company (NYSE: LLY), today urged that biopharmaceuticals be included ...
Company management will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please contact your Canaccord representative or email tim@lifesciadvisors.com.